4//SEC Filing
Dahan Michel 4
Accession 0001562180-22-002163
CIK 0001517022other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 9:11 PM ET
Size
18.6 KB
Accession
0001562180-22-002163
Insider Transaction Report
Form 4
Dahan Michel
SVP, Chief Business Officer
Transactions
- Sale
Common Stock
2022-02-28$2.15/sh−6,555$14,125→ 258,995 total - Award
Common Stock
2022-02-28+50,000→ 308,995 total - Sale
Common Stock
2022-03-01$2.17/sh−6,873$14,919→ 302,122 total - Sale
Common Stock
2022-03-01$2.17/sh−6,873$14,919→ 295,249 total - Sale
Common Stock
2022-03-01$2.17/sh−1,232$2,674→ 297,017 total - Award
Employee Stock Option (Right to buy)
2022-02-28+200,000→ 200,000 totalExercise: $2.16Exp: 2032-02-28→ Common Stock (200,000 underlying)
Footnotes (7)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.
- [F2]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
- [F3]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2019.
- [F4]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.
- [F5]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.
- [F6]Includes 1,500 shares of the Issuers common stock purchased on June 30, 2021 and 1,500 shares of the Issuers common stock purchased on December 31, 2021, each under the Issuers 2014 Amended and Restated Employee Stock Purchase Plan.
- [F7]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001669737
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 9:11 PM ET
- Size
- 18.6 KB